
1.49 Delayed Data As of Mar 24 | ![]() Today’s Change | 0.82 Today|||52-Week Range 3.88 | +49.18% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $57.7M |
TCR2 Therapeutics, Inc. 100 Binney Street Cambridge Massachusetts 02142 |
Garry E. Menzel | President, Chief Executive Officer & Director |
Peter Olagunju | Chief Operating Officer |
Eric M. Sullivan | Chief Financial Officer |
Alfonso Quintás-Cardama | Chief Medical Officer |
Praveen Malhotra | Vice President-Information Technology |